Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: Review of the literature;Impact cognitif, émotionnel et comportemental d'un résultat BRCA1/2 incertain: Revue de la littérature

Bulletin du Cancer

Volumn 98, Issue 2, 2011, Pages 184-198

  Leblond, Débora ^a,b   Brédart, Anne ^a,b   Dolbeault, Sylvie ^a,c,d   De Pauw, Antoine ^e   Lyonnet, Dominique Stoppa ^e   Flahault, Cécile ^a,b   Sultan, Serge ^b  

^a INSTITUT CURIE   (France)

^b Sorbonne Paris Cité   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Breast cancer; Emotional distress; Health behaviors; Psychological impact; Risk perception; Testing for genetic predisposition

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BEHAVIOR; BREAST CANCER; CANCER DIAGNOSIS; COGNITION; CONSULTATION; DISTRESS SYNDROME; EMOTION; FAMILY HISTORY; GENETIC ANALYSIS; HUMAN; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL HISTORY; OUTCOME ASSESSMENT; OVARY CANCER; REVIEW;

EID: 79953253612     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1309     Document Type: Review

References (47)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994 ; 266 : 66-71. (Pubitemid 24345325)
2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995 ; 378 : 789-92. (Pubitemid 26004412)
3. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007 ; 25 : 1329-33. (Pubitemid 46706879)
4. Stoppa-Lyonnet D, Gauthier-Villar M, Coupier I, This P, Andrieu N. Diagnostic des patients à risque de cancer du sein. In : Namer M, Héry M, Serin D, Spielmann M, editors. Cancer du sein. Compte-rendu du cours supérieur francophone de cancérologie (Saint-Paul-de-Vence, 13-15 janvier 2005). Paris : Springer, 2006, p. 15-40.
5. Bonadona V, Saltel P. « La mission de messager » dévolue au patient consultant en onco-génétique : enjeux psychologiques. In : Prédisposition génétique aux cancers : questions psychologiques et débats de société. Paris : Éditions John Libbey, 2005.
6. Vink GR, van Asperen CJ, Devilee P, Breuning MH, Bakker E. Nationwide survey about the policy of testing and counselling of unclassified variants in BRCA1 and BRCA2. Fam Cancer 2003 ; 2 : 228.
7. Eisinger F, Bressac B, Castaigne D, et al. Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour 2004). Bull Cancer 2004 ; 91 : 219-37. (Pubitemid 38534706)
8. Vadaparampil ST, Mireea CA,Wilsona C, Jacobsen PB. Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis 2006, 2007 ; 27 : 97-108.
9. Meiser B, Tucker K, Friedlander M, et al. Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 2008 ; 10 : 216-30.
10. Payne K, Nicholls S, McAllister M, MacLeod R, Donnai D, Davies LM. Outcome measurement in clinical genetics services: a systematic review of validated measures. Value Health 2008 ; 11 : 497-508. (Pubitemid 351712973)
11. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992 ; 84 : 24-30.
12. Lindberg NM, Wellisch D. Anxiety and compliance among women at high risk for breast cancer. Ann Behav Med 2001 ; 20 : 298-303. (Pubitemid 33134836)
13. Patenaude AF. Genetic testing for cancer. Psychological approaches for helping patients and families. Washington, DC: American Psychological Society, 2005.
14. Dolbeault S, Flahault C, Stoppa-Lyonnet D, Brédart A. Communication in genetic counselling for breast/ovarian cancer. Recent Results Cancer Res 2006 ; 168 : 23-36.
15. Gurmankin AD, Domchek S, Stopfer J, Fels C, Armstrong K. Patients' resistance to risk information in genetic counseling for BRCA1/2. Arch Intern Med 2005 ; 165 : 523-9. (Pubitemid 40344383)
16. De Pauw A, Stoppa-Lyonnet D, Andrieu N, Asselain B. Estimation du risque individuel de cancer du sein : intérêt et limites des modèles de calcul de risque. Bull Cancer 2009 ; 96 : 979-88.
17. van Dooren S, Rijnsburger A, Seynaeve C, et al. Psychological distress in women at increased risk for breast cancer: the role of risk perception. Eur J Cancer 2004 ; 40 : 2056-63. (Pubitemid 39165538)
18. Brédart A, De Pauw A, Flahault C, Stoppa-Lyonnet D, Dolbeault S. Facteurs de risques génétiques. In : Razavi D, Delvaux N, editors. Précis de psycho-oncologie de l'adulte. Paris : Masson, 2008, p. 45-62.
19. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, et al. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006 ; 17 : 1090-5. (Pubitemid 43985244)
20. van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003 ; 21 : 3867-74. (Pubitemid 46606243)
21. Schlich-Bakker KJ, ten Kroode HFJ, Ausems MGEM. A literature review of the psychological impact of genetic testing on breast cancer patient. Patient Educ Couns 2006 ; 62 : 13-20. (Pubitemid 43832070)
22. Bish A, Sutton S, Jacobs C, Levene S, Ramirez A, Hodgson S. No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches. Genet Med 2002 ; 4 : 353-8. (Pubitemid 44698549)
23. Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002 ; 6 : 79-87.
24. Cypowyj C, Eisinger F, Huiart L, Sobol H, Morin M, Julian- Reynier C. Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives. Psychooncology 2009 ; 18 : 209-15.
25. Vos J, Otten W, van Asperen C, Jansen A, Menko F, Tibben A. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. Psychooncology 2008 ; 17 : 822-30.
26. Beran TM, Stanton AL, Kwan L, et al. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?. Ann Behav Med 2008 ; 36 : 107-16.
27. Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002 ; 20 : 514-20. (Pubitemid 34072536)
28. Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psychooncology 2008 ; 17 : 767-73.
29. van Dijk S, van Asperen CJ, Jacobi CE, et al. Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message. Genet Test 2004 ; 8 : 235-9. (Pubitemid 39586791)
30. van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol 2006 ; 24 : 3672-7. (Pubitemid 46630543)
31. Dorval M, Gauthier G, Maunsell E, et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 2005 ; 14 : 2862-6.
32. van Dijk S, Otten W, Timmermans DR, et al. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 2005 ; 7 : 239-45. (Pubitemid 40638069)
33. Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004 ; 22 : 1823-9. (Pubitemid 41095172)
34. Couch FJ, Hartmann LC. BRCA1 testing: advances and retreats. JAMA 1998 ; 25 : 955-7.
35. Lerman C, Hughes C, Lemon SJ, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998 ; 16 : 1650-4.
36. Maheu C, Thorne S. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience. Res Nurs Health 2008 ; 31 : 553-62.
37. Croyle RT, Lerman C. Psychological impact of genetic testing. In : Croyle RT, editor. Psychosocial effects of screening for disease prevention and detection. New York : Oxford University Press, 1995, p. 11-38.
38. Baty BJ, Dudley WN, Musters A, Kinney AY. Uncertainty in BRCA1 cancer susceptibility testing. Am J Med Genet C Semin Med Genet 2006 ; 142C : 241-50. (Pubitemid 44747451)
39. Evers-Kierbooms G. Risk communication in genetic counselling and genetic risk perception. Eur Rev Appl Psychol 1995 ; 45 : 23-8.
40. Julian-Reynier C. Communication des risques en oncogéné tique : impact sur les croyances et comportements de santé. Rev Fr Psychooncologie 2006 ; 5 : 9-13.
41. O'Neill SC, DeMarco T, Peshkin BN, et al. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.. Am J Med Genet C Semin Med Genet 2006 ; 142C : 251-9. (Pubitemid 44747452)
42. Derogatis L. SCL-90-R administration, scoring, and procedures manual II. Towson, MD: Clinical Psychometric Research, 1983.
43. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosomatic Med 1979 ; 41 : 209-18. (Pubitemid 9219271)
44. Spielberger CD, Gorsuch R, Lushene R. The state-Trait Personality Inventory (STAI, form Y). Palo Alto, CA, Consulting Psychologists Press, 1983.
45. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatry Scand 1983 ; 67 : 361-70. (Pubitemid 13098606)
46. Holland JC. Update. NCCN Practice guidelines for the management of psychological distress. Oncology 1999 ; 13 : 459-507.
47. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 1993 ; 28 : 145-55. (Pubitemid 24056086)